Pharmacyclics Reports Fiscal 2012 Third Quarter Financial Results and Recent ... Sacramento Bee The poster discussion session will highlight data from the ibrutinib Phase Ib CLL combination trial with bendamustine and rituximab in relapsed or refractory patients. Oral Presentation Date/Time: Monday, June 4, 2012; 10:15 AM – 10:30 AM (CT) ... |
